"St. Luke's is a faith-based, nonprofit healthcare provider committed to improving the quality of life for our patients and the community. Our compassionate healthcare team furthers this mission by providing high quality, nationally-recognized care and achieving excellent patient satisfaction."

During the past decade, Saint Luke's Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 61 clinical trials were completed, i.e. on average, 108.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 37 clinical trials were completed. i.e. 231.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "NSABP Foundation Inc" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's Hospital" are "Breast Cancer" (14 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Adenocarcinoma" (5 trials) and "HER2/Neu Negative" (5 trials). Many other conditions were trialed in "Saint Luke's Hospital" in a lesser frequency.

Most popular intervention types in "Saint Luke's Hospital" are "Drug" (94 trials), "Other" (66 trials), "Biological" (38 trials), "Procedure" (21 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (22 trials), "Nivolumab" (13 trials), "Placebo" (13 trials) and "Biospecimen Collection" (11 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's Hospital" are 100 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Luke's Hospital". undefined are not yet recruiting, 19 are recruiting, 45 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 44 completed trials in Saint Luke's Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's Hospital, 4 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

Saint Luke's Hospital has several departments that took part in Clinical trials: "Center for Cancer Care and Research" - 48 trials, "Sleep Medicine & Research Center, St. Luke's Hospital" - 20 trials